表紙
市場調査レポート

日本の糖尿病市場:患者数、有病率、経口抗糖尿病薬、インスリン、診断

Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics

発行 IMARC Services Pvt. Ltd. 商品コード 345919
出版日 ページ情報 英文 44 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
日本の糖尿病市場:患者数、有病率、経口抗糖尿病薬、インスリン、診断 Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics
出版日: 2016年03月23日 ページ情報: 英文 44 Pages
概要

当レポートでは、日本の糖尿病市場について調査分析し、現在・将来の動向 (有病率、人口統計、診断、治療) について検証し、疫学、市場動向、治療構造、競合構造、市場の見通しなど、体系的な情報を提供しています。

第1章 調査手法

第2章 エグゼクティブサマリー

第3章 糖尿病の概要

  • 糖尿病とは
  • 糖尿病の診断と治療
  • 糖尿病の合併症

第4章 日本における糖尿病市場を促進する主な要因

第5章 日本の糖尿病の疫学

  • 糖尿病人口と有病率
  • 人口と有病率:糖尿病タイプ (1型・2型) 別
  • 人口と有病率:地域別
  • 人口と有病率:性別
  • 人口と有病率:年齢層別
  • 糖尿病の診断と薬物治療率

第6章 日本の糖尿病市場

  • 過去の市場動向
  • 市場の見通し
  • 市場内訳:セグメント別
  • 日本の経口抗糖尿病薬市場
  • 日本のインスリン市場

第7章 日本の糖尿病診断市場

  • 過去の市場動向
  • 市場セグメント
  • 主要企業

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: SRP00116CM

IMARC's new report "Japan Diabetes Market Report: Patients, Prevalence, Oral Antidiabetics, Insulin and Diagnostics " provides an analytical and statistical insight into the Japanese diabetes market. The report provides both current and future trends in the prevalence, demographical breakup, diagnosis and treatment of diabetes in Japan. The research study serves as an exceptional tool to understand the epidemiology, market trends, therapeutic structure, competitive structure and the outlook of the Japan diabetes market. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the Japan diabetes market in any form.

What we have achieved in this report:

Comprehensive situation analysis of the Japanese diabetes epidemiology and its dynamics:

Focus of the Analysis:

  • Historical, current and future prevalence of diabetes in Japan
  • Historical, current and future prevalence of type-1 and type-2 diabetes in Japan
  • Historical, current and future prevalence of diabetes in the urban and rural regions in Japan
  • Historical, current and future prevalence of diabetes among males and females in Japan
  • Historical, current and future prevalence of diabetes among various age groups in Japan
  • Historical, current and future diagnosis rates for diabetes in Japan
  • Historical, current and future drug treatment rates for diabetes in Japan

Comprehensive situation analysis of the Japanese Oral Antidiabetics market and its dynamics:

Focus of the Analysis:

  • Performance of the Oral Antidiabetics market in Japan
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the Japanese Insulin market and its dynamics:

Focus of the Analysis:

  • Performance of the Insulin market in Japan
  • Performance of key classes
  • Performance of key players
  • Market outlook

Comprehensive situation analysis of the Japanese diabetes diagnostics market and its dynamics:

Focus of the Analysis:

  • Performance of the diabetes diagnostics market in Japan
  • Market Segmentation
  • Key players
  • Market outlook

image1

Table of Contents

1 Research Methodology

2 Executive Summary

3 Diabetes Disease Overview

  • 3.1 What is Diabetes?
  • 3.2 Diabetes Diagnosis and Treatment
    • 3.2.1 Diagnosis
    • 3.2.2 Treatment
    • 3.3 Diabetes Complications

4 Key Factors Driving the Diabetes Market in Japan

5 Japan Diabetes Epidemiology

  • 5.1 Diabetes Population and Prevalence Rates
  • 5.2 Population and Prevalence Rates by Diabetes Type (Type-1 and Type-2)
  • 5.3 Population and Prevalence Rates by Region
  • 5.4 Population and Prevalence Rates by Gender
  • 5.5 Population and Prevalence Rates by Age Group
  • 5.6 Diabetes Diagnosis and Drug Treatment Rates

6 Japan Diabetes Market

  • 6.1 Historical Market Trends
  • 6.2 Market Outlook
  • 6.3 Market Breakup by Segment
  • 6.4 Japan Oral Antidiabetics Market
    • 6.4.1 Historical Market Trends
    • 6.4.2 Market Breakup by Class
    • 6.4.3 Market Shares of Key Players
    • 6.4.4 Market Outlook
  • 6.5 Japan Insulin Market
    • 6.5.1 Historical Market Trends
    • 6.5.2 Market Breakup by Class
    • 6.5.3 Market Shares of Key Players
    • 6.5.4 Market Outlook

7 Japan Diabetes Diagnostics Market

  • 7.1 Historical Market Trends
  • 7.2 Market Segmentation
  • 7.1 Key Players

List of Figures

  • Figure 3 1: The impact of Diabetes in the Human Body
  • Figure 3 2: Diabetes Complications
  • Figure 4 1: Global: Breakup of Diabetes Patients by Region, (in %) 2015 & 2035
  • Figure 4 2: Japan: Overweight & Obese Population* (in Million), 2010, 2015. 2020
  • Figure 4 3: Body Mass Index and Relative risk of Type-2 Diabetes
  • Figure 4 4: Japan: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in %),
  • Figure 4 5 : Japan: Diabetes Prevalence By Age Groups, (in %),
  • Figure 5 1: Japan: Total Number of Diabetes Patients* (in 000), 2008-2015
  • Figure 5 2: Japan: Total Number of Diabetes Patients* Forecast (in 000), 2016-2020
  • Figure 5 3: Japan (Type1 & Type2): Total Number of Diabetes Patients* (in 000), 2008- 2015
  • Figure 5 4: India (Type1 & Type2): Total Number of Diabetes Patients* (in 000),2016-2020
  • Figure 5 5: Japan (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2008 - 2015
  • Figure 5 6: Japan (Urban & Rural): Total Number of Diabetes Patients* (in 000), 2016 - 2020
  • Figure 5 7: Japan (Male & Female): Total Number of Diabetes Patients* (in 000), 2008 - 2015
  • Figure 5 8: Japan (Male & Female): Total Number of Diabetes Patients* (in 000), 2016 - 2020
  • Figure 5 9: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2008 - 2015
  • Figure 5 10: Japan: Total Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (in 000), 2016 - 2020
  • Figure 6 1: Japan: Diabetes Drugs Market (in Million US$), 2008-2015
  • Figure 6 2: Japan: Diabetes Drug Market Forecast (in Million US$), 2016-2020
  • Figure 6 3: Japan: Diabetes Drugs Market Forecast: Breakup of Insulin and Oral Antidiabetics (in %), 2016-2020
  • Figure 6 4: Japan: Diabetes Drugs Market: Breakup of Insulin and Oral Antidiabetics (in %), 2008-2015
  • Figure 6 5: Japan: Oral Antidiabetics Market: (in Million US$), 2008-2015
  • Figure 6 6: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2008&2015
  • Figure 6 7: India: Oral Anti-diabetics Market: Sales Share of Key Players (in %),
  • Figure 6 8: Japan: Oral Antidiabetics Market: (in Million US$), 2016-2020
  • Figure 6 9: Japan: Oral Antidiabetics Market: Sales Share of Key Classes (in %), 2016 &2020
  • Figure 6 10: Japan: Insulin Market, (in Million US$), 2008-2015
  • Figure 6 11: Japan: Breakup of Insulin Market by Class (in %)
  • Figure 6 12: Japan: Insulin Market: Sales Share of Key Players (in %)
  • Figure 6 13: Japan: Insulin Market Forecast (in Million US$), 2016-2020
  • Figure 7 1: Japan: Diabetes Diagnostics Market (in Million US$), 2008-2015
  • Figure 7 2: Japan: Diabetes Diagnostics Market: Sales by Segment (in %)
  • Figure 7 3: Japan: Diabetes Diagnostics Market Forecast (in Million US$), 2016-2020

List of Tables

  • Table 3 1: Diagnosis of Diabetes
  • Table 4 1: Global: Diabetes Population Breakup by Country (in 000's), 2015 & 2035
  • Table 4 2: Japan: Overweight &Obesity Statistics, 2010, 2015 & 2020
  • Table 4 3: Japan: Breakup of Total Population by Age Groups (0-14, 15-64 & 65+), (in Million),
  • Table 5 1: Japan: Total Prevalence &Number of Diabetes Patients*, 2008, 2015 & 2020
  • Table 5 2: Japan (Type1 & Type2): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
  • Table 5 3: Japan (Urban & Rural): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
  • Table 5 4: Japan (Male & Female): Total Prevalence & Number of Diabetes Patients, 2008, 2015 & 2020
  • Table 5 5: Total Prevalence & Number of Diabetes Patients by Age Group (20-39), (40-59) & (60-79) (In Millions), 2008, 2015 & 2020
Back to Top